| 发明名称 |
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG UND/ODER VORBEUGUNG UND/ODER FETTLEIBIGKEIT IM ZUSAMMENHANG STEHT |
| 摘要 |
<p>A pharmaceutical composition comprising a nucleic acid (I) that encodes a 5-HT4 receptor (II), or its equivalent, for treatment and/or prevention of a disorder associated with obsessional behavior, is new. An Independent claim is also included for a method of identifying compounds (III) suitable for treating a disorder associated with obsessional behavior.</p> |
| 申请公布号 |
DE60335892(D1) |
申请公布日期 |
2011.03.10 |
| 申请号 |
DE2003635892 |
申请日期 |
2003.10.31 |
| 申请人 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) |
发明人 |
COMPAN, VALERIE RESIDENCE LE |
| 分类号 |
C12N15/12;A61K38/00;A61K38/18;A61P25/00;A61P25/30;C07K14/705;G01N33/50 |
主分类号 |
C12N15/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
